Lok Sabha Question No. 1430 (UNSTARRED), answered on 2023-02-10
Subject: PLI for Neutraceuticals and Dietary Supplements
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Vincent H Pala, Jagdambika Pal

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION No. 1430 TO BE ANSWERED ON THE 10 th  February, 2023

PLI for Neutraceuticals and Dietary Supplements

## 1430.   SHRI VINCENT H. PALA: SHRI JAGDAMBIKA PAL:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a) whether the Government has plans to introduce a PLI (Production Linked Incentive) scheme or Research Linked Incentive scheme for nutraceuticals and dietary supplements;
- (b) if so, the details thereof;

(c) the details on the status of the progress made by the Task Force on Nutraceuticals under the Principal Scientific Advisor;

(d)  whether  the  Government  has  plans  to  introduce  any  other  support  for  the  domestic manufacturing of Active Pharmaceutical Ingredients (APIs) besides the existing PLI scheme; and

(e) if so, the details thereof?

## ANSWER

## MINISTER OF STATE IN THE MINISTRY OF CHEMICALS & FERTILIZERS (SHRI BHAGWANTH KHUBA)

- (a) and (b):  The Department of Pharmaceuticals is not handling the subject of nutraceuticals and dietary supplements.
- (c):  As per information received from Office of Principle Scientific Advisor, a Task Force on Nutraceutical Sector under the Chairmanship of the Principal Scientific Adviser to GoI (PSA to  GoI)  was  constituted  in  December,  2021  to  evolve  a  road  map  to  provide  a  thrust to Nutraceutical Sector and facilitate unlocking the sectors' growth potential by addressing the challenges the industry is facing.  So far, three meetings of Task Force have been held and formation of the Nutraceutical Panel has been done under the Department of Commerce
- (d) & (e): The Department of Pharmaceuticals Department implements various programmes to minimize country's dependence on imports and to give fillip to indigenous manufacturing of Active Pharmaceutical Ingredients (APIs) / Bulk Drugs and the details are as follows :
- i. Production Linked Incentive (PLI) Scheme for Bulk Drugs, with a financial outlay of Rs.  6,940  crores  and  the  tenure  from  FY  2020-2021  to  FY  2029-30,  provides  for financial incentive for 41 identified products. Out of these, 21 projects have already been commissioned with the installed capacity of 33,895 MT.
- ii. The Production Linked Incentive Scheme for Pharmaceuticals, with a financial outlay Rs. 15,000 crores and the tenure from FY 2020- 2021 to FY 2028-29, provides for financial incentive to 55 selected applicants for manufacturing of identified products under three categories for a period of six year. The eligible drugs under this scheme also include APIs.
- iii. Scheme for Promotion of Bulk Drug Parks, with a financial outlay of Rs. 3,000 crores and the tenure from FY 2020-2021 to FY 2024-25, provides for financial assistance of Rs 1000 crore each to the State of Himachal Pradesh, Andhra Pradesh and Gujarat for establishing Bulk Drug Parks. The financial assistance will be  given for creation of common infrastructure facilities which will be used by the industrial units which will get established in these Parks.

*****